Our Business

Innovation in business

Research and Development has been the foundation of our success and continues to be the major driver of innovative new medicines for the treatment of diseases with an unmet therapeutic need.

 

Boehringer Ingelheim is committed to providing products that enhance health and quality of life for people and animals now and into the future.

Australia and New Zealand

In Australia and New Zealand, our company is active in three divisions, Prescription Medicine, Consumer Health Care and Animal Health. We also own and manage several Duboisia Farms in Queensland, Australia which truly makes our products 'home grown'.

Our Business Areas:

  • Prescription Medicine

    We provide a wide and expanding range of prescription products to patients throughout Australia and New Zealand.

  • Consumer Health Care

    We produce a wide range of products to consumers via retail pharmacies. They include well known brands such as Bisolvon®, Buscopan®, Dulcolax® and Dulcofibre®.

  • Animal Health

    We offer a broad range of trusted veterinary products for both pets and production animals in Australia and New Zealand.

  • Duboisia Farms

    A unique feature of our company is the production and distribution of the native Australian plant, 'Duboisia' - a key ingredient in several of our major global and local products.

Corporate Website

Visit our corporate website for more information on Boehringer Ingelheim.

Research & Development

From curiosity to discovery... Learn about Research and Development at Boehringer Ingelheim